About Columbia Labs

Columbia Laboratories (Nasdaq:CBRX) has a rich history in drug development. We offer broad formulation, development, manufacturing and analytical capabilities through our wholly-owned subsidiary, Molecular Profiles Ltd. Learn More

In the News

Molecular Profiles Ltd.

Founded in 1997 to provide high-end pharmaceutical analysis, Molecular Profiles is a world-class research provider successfully servicing both emerging and multi-national pharmaceutical companies and supporting the development of novel drugs.


Partners & Products

We commercialize our products through strategic alliances with partners including:


Our stringent criteria ensure our partners have the market knowledge and sales force capacity to sell our products in the specific markets they will address.

Current Events

28 Oct 2014: CBRX Q3 2014 Conference Call archive 

09 Sept 2014: CBRX presentation at Rodman & Renshaw 16th Annual Global Investment Conference - archive   

CBRX Presentation

Download Columbia's investor presentation PDF